Long-term visual and anatomical outcomes following anti-VEGF monotherapy for retinal angiomatous proliferation

British Journal of Ophthalmology

Volumn 94, Issue 6, 2010, Pages 701-705

  Hemeida, Tarek S ^a   Keane, Pearse A ^a   Dustin, Laurie ^a   Sadda, Srinivas R ^a   Fawzi, Amani A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEVACIZUMAB; RANIBIZUMAB;

AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HUMAN; MALE; MEDICAL RECORD REVIEW; OPTICAL COHERENCE TOMOGRAPHY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETINA DISEASE; RETINA FLUORESCEIN ANGIOGRAPHY; RETINA MACULA AGE RELATED DEGENERATION; RETINAL ANGIOMATOUS PROLIFERATION; RETROSPECTIVE STUDY; VISUAL ACUITY;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; DRUG EVALUATION; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MACULAR DEGENERATION; MALE; RETROSPECTIVE STUDIES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY;

EID: 77953730720     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.167627     Document Type: Article

References (25)

1. Yannuzzi LA, Negrão S, Iida T, et al. Retinal angiomatous proliferation in age-related macular degeneration. Retina 2001;21:416-34. (Pubitemid 32971350)
2. Monson DM, Smith JR, Klein ML, et al. Clinicopathologic correlation of retinal angiomatous proliferation. Arch Ophthalmol 2008;126:1664-8.
3. Gross NE, Aizman A, Brucker A, et al. Nature and risk of neovascularization in the fellow eye of patients with unilateral retinal angiomatous proliferation. Retina 2005;25:713-18. (Pubitemid 41254540)
4. Bottoni F, Massacesi A, Cigada M, et al. Treatment of retinal angiomatous proliferation in age-related macular degeneration: a series of 104 cases of retinal angiomatous proliferation. Arch Ophthalmol 2005;123:1644-50. (Pubitemid 41785096)
5. Bressler NM. Retinal anastomosis to choroidal neovascularization: a bum rap for a difficult disease. Arch Ophthalmol 2005;123:1741-3.
6. Boscia F, Parodi MB, Furino C, et al. Photodynamic therapy with verteporfin for retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 2006;244:1224-32. (Pubitemid 44463458)
7. Gragoudas ES, Adamis AP, Cunningham ET Jr, et al. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805-16.
8. Spaide RF, Laud K, Fine HF, et al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 2006;26:383-90.
9. Rosenfeld PJ, Brown DM, Heier JS, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-31.
10. Kaiser PK, Blodi BA, Shapiro H, et al. MARINA Study Group. Angiographic and optical coherence tomographic results of the MARINA study of ranibizumab in neovascular age-related macular degeneration. Ophthalmology 2007;114:1868-75.
11. Bashshur ZF, Haddad ZA, Schakal A, et al. Intravitreal bevacizumab for treatment of neovascular age-related macular degeneration: a one-year prospective study. Am J Ophthalmol 2008;145:249-56.
12. Meyerle CB, Freund KB, Iturralde D, et al. Intravitreal bevacizumab (Avastin) for retinal angiomatous proliferation. Retina 2007;27:451-7.
13. Joeres S, Heussen FM, Treziak T, et al. Bevacizumab (Avastin) treatment in patients with retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 2007;245:1597-602.
14. Costagliola C, Romano MR, dell'Omo R, et al. Intravitreal bevacizumab for the treatment of retinal angiomatous proliferation. Am J Ophthalmol 2007;144:449-51. (Pubitemid 47336935)
15. Ghazi N, Knape R, Kirk T, et al. Intravitreal bevacizumab (Avastin) treatment of retinal angiomatous proliferation. Retina 2008;28:689-95. (Pubitemid 351655120)
16. Lai TY, Chan WM, Liu DT, et al. Ranibizumab for retinal angiomatous proliferation in neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2007;245:1877-80.
17. Ip MS, Scott IU, Brown GC, et al. Anti-vascular endothelial growth factor pharmacotherapy for age-related macular degeneration. a report by the American Academy of Ophthalmology. Ophthalmology 2008;115:1837-46.
18. Lalwani G, Rosenfeld P, Fung A, et al. A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO study. Am J Ophthalmol 2009;148:43-58.
19. Rouvas A, Papakostas T, Vavvas D, et al. Intravitreal ranibizumab, intravitreal ranibizumab with PDT, and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation. Retina 2009;29:536-44.
20. Forooghian F, Cukras C, Meyerle C, et al. Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema. Invest Ophthalmol Vis Sci 2008;49:4290-6.
21. Keane PA, Liakopoulos S, Ongchin SC, et al. Quantitative subanalysis of optical coherence tomography after treatment with ranibizumab for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2008;49:3115-20.
22. Bearelly S, Espinosa-Heidmann DG, Cousins SW. The role of dynamic indocyanine green angiography in the diagnosis and treatment of retinal angiomatous proliferation. Br J Ophthalmol 2008;92:191-6. (Pubitemid 351224093)
23. Shimada H, Kawamura A, Mori R, et al. Clinicopathological findings of retinal angiomatous proliferation. Graefes Arch Clin Exp Ophthalmol 2007;245:295-300.
24. Spaide R. The as-needed treatment strategy for choroidal neovascularization: A feedback-based treatment system. Am J Ophthalmol 2007;143:679-80.
25. Viola F, Massacesi A, Orzalesi N, et al. Retinal angiomatous proliferation natural history and progression of visual loss. Retina 2009;29:732-9.